Cochrane for Clinicians

Putting Evidence into Practice

Calcium Supplementation for Preventing Hypertensive Disorders in Pregnancy

 


FREE PREVIEW. AAFP members and paid subscribers: Log in to get free access. All others: Purchase online access.


FREE PREVIEW. Purchase online access to read the full version of this article.

Am Fam Physician. 2015 Oct 1;92(7):570-571.

Author disclosure: No relevant financial affiliations.

Clinical Question

Does calcium supplementation prevent hypertensive disorders in pregnancy?

Evidence-Based Answer

High-dose calcium supplementation (i.e., at least 1,000 mg per day) during pregnancy reduces the risk of developing hypertension and preeclampsia. The most significant risk reduction occurs in women at risk of hypertensive disorders and those with low-calcium diets. (Strength of Recommendation: A, based on consistent, good-quality patient-oriented evidence.)

Practice Pointers

Hypertensive disorders occur in up to 10% of pregnancies and are a major source of fetal and maternal morbidity and mortality.1 Although early recognition and treatment have improved some outcomes, the pathogenesis of preeclampsia spectrum disorders is still not well understood. The incidence of all hypertensive disorders of pregnancy is increasing in the United States, making the need for prevention even greater. More than one-half of women of childbearing age do not have adequate calcium intake.2

The authors identified 13 randomized controlled trials (RCTs) comparing high-dose calcium supplementation (at least 1,000 mg per day) with placebo or no calcium in 15,730 women. Meta-analysis showed a risk reduction with calcium supplementation for hypertension (relative risk = 0.65; 95% confidence interval [CI], 0.53 to 0.81) and for preeclampsia (relative risk = 0.45; 95% CI, 0.31 to 0.65). Eight of the RCTs looked specifically at women with low-calcium diets (less than 900 mg per day). These trials included 10,678 women, and found even greater risk reduction for hypertensive disorders with calcium supplementation (relative risk = 0.36; 95% CI, 0.20 to 0.65). There was also a decrease in preterm births, but no difference in neonatal intensive care unit (NICU) admissions or stillbirths. Overall, the number needed to treat (NNT) to prevent one case of preeclampsia in the general population is 28, and in patients at high risk of preeclampsia, the NNT is 7.

The authors also examined 10 RCTs that evaluated low-dose calcium supplementation in 2,234 women. Although there were reductions in hypertension, preeclampsia, NICU admissions, and preterm birth, most of the participants were already at high risk of preeclampsia. Because of the high risk of bias and small sample size, more studies are needed to determine the effectiveness of recommending low-dose calcium supplementation.

In persons with low-calcium diets who are at high risk of hypertensive disorders, calcium supplementation could prevent the development of these disorders. Based in part on this Cochrane review, the World Health Organization recommends supplementing at-risk pregnant women with the equivalent of 1.5 to 2.0 g of elemental calcium daily (i.e., 3,750 to 5,000 mg of calcium carbonate daily).3 Family physicians should consider calcium supplementation in conjunction with other recommendations for preventing pregnancy-related hypertensive disorders.

Author disclosure: No relevant financial affiliations.


The practice recommendations in this activity are available at http://summaries.cochrane.org/CD001059.

SOURCE:

Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014;(6):CD001059.

REFERENCES

1. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.

2. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr. 2010;140(4):817–822.

3. World Health Organization. Guideline: calcium supplementation in pregnant women. Geneva, Switzerland: WHO; 2013. http://apps.who.int/iris/bitstream/10665/85120/1/9789241505376_eng.pdf?ua=1. Accessed June 5, 2015.

These are summaries of reviews from the Cochrane Library.

This series is coordinated by Corey D. Fogleman, MD, Assistant Medical Editor.

A collection of Cochrane for Clinicians published in AFP is available at http://www.aafp.org/afp/cochrane.



 

Copyright © 2015 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Dec 1, 2016

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article